FDA observation outcomes at Aurobindo Pharma's Raleigh facility have moved into a new phase after the US regulator classified the site as Voluntary Action Indicated
.png "Sun Pharma Gets Major Relief in Lipitor Antitrust Litigation")
Sun Pharma has secured major relief in its long-running Antitrust litigation in the U.S. The company said a U.S. appeals court upheld a lower court ruling in its favor. The case relates to generic Lipitor and a patent settlement involving Ranbaxy...
The latest pharma updates spotlight key developments in drug safety, regulatory compliance, clinical practice, disease preparedness and global ambitions
Chandipura Virus cases have surged in Gujarat, with the death toll reaching 27. The state has reported 41 confirmed infections so far. The outbreak has raised concern due to the virus's rapid progression. Chandipura virus cases have mainly been...
India’s pharmaceutical sector opened FY27 with mixed but largely positive results across exports, domestic sales, and global markets. Pharma exports rose 6.8 percent year over year to USD 8.1 billion in Q1 FY27. Several drugmakers also...
Manufacturing quality at Aurobindo Pharma's Eugia business faces renewed scrutiny after the US Food and Drug Administration issued a warning letter to its Unit-I facility in Telangana
Drug quality has become a bigger regulatory priority in India as authorities intensify inspections to strengthen manufacturing standards
Osteoarthritis treatment could see a new stem cell-based approach after Bengaluru-based Stempeutics Research secured a US patent.
Drug Resistance is becoming harder to manage as bacteria stop responding to commonly used antibiotics. Wockhardt is now targeting this challenge through a new scientific learning platform.
Drug approvals, MedTech innovation, and pharma legal battles are driving major healthcare developments across global and Indian markets
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")